Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention

Citations Over TimeTop 1% of 2020 papers

Abstract

Cancer treatments are often more successful when the disease is detected early. We evaluated the feasibility and safety of multicancer blood testing coupled with positron emission tomography-computed tomography (PET-CT) imaging to detect cancer in a prospective, interventional study of 10,006 women not previously known to have cancer. Positive blood tests were independently confirmed by a diagnostic PET-CT, which also localized the cancer. Twenty-six cancers were detected by blood testing. Of these, 15 underwent PET-CT imaging and nine (60%) were surgically excised. Twenty-four additional cancers were detected by standard-of-care screening and 46 by neither approach. One percent of participants underwent PET-CT imaging based on false-positive blood tests, and 0.22% underwent a futile invasive diagnostic procedure. These data demonstrate that multicancer blood testing combined with PET-CT can be safely incorporated into routine clinical care, in some cases leading to surgery with intent to cure.

Related Papers

• → Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention(2020)644 cited
• → Positron emission tomography: a technical introduction for clinicians(2002)29 cited
• Positron Emission Tomography (PET) in Oncology: A Systematic Review of Clinical Effectiveness and Indications for Use.(2010)
• The current state of positron emission tomography.(1991)
• → New cancer blood test developed(2018)